Skip to content
healthcare.dev

Ojjaara

NDC 81864-101, Momelotinib, tablet, from GlaxoSmithKline LLC.

Product NDC
81864-101
Status
Listed
Labeler
GlaxoSmithKline LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216873
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81864-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE200 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]

Package NDCNDC-11Package
81864-101-308186401013030 TABLET in 1 BOTTLE (81864-101-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4a672fd1-eb7b-4aa9-9b23-845e4b5dc400

Use it

Look up 81864-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81864-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81864-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.